Myocardial Injury Clinical Trials

20 recruiting

Myocardial Injury Trials at a Glance

24 actively recruiting trials for myocardial injury are listed on ClinicalTrialsFinder across 6 cities in 27 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Ottawa, Basel, and Ann Arbor. Lead sponsors running myocardial injury studies include University Hospital, Basel, Switzerland, Cantonal Hospital of St. Gallen, and Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica.

Browse myocardial injury trials by phase

Treatments under study

About Myocardial Injury Clinical Trials

Looking for clinical trials for Myocardial Injury? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Myocardial Injury trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Myocardial Injury clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting
Phase 2

Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.

Myocardial InjuryMyocardial Infarction, AcuteMyocardial Infarction With Nonobstructive Coronary Arteries
NHS National Waiting Times Centre Board400 enrolled2 locationsNCT05198791
Recruiting
Phase 4

Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic Surgery

Thoracoscopic SurgeryThoracic DiseasesMyocardial Injury
Tongji Hospital1,058 enrolled1 locationNCT07028593
Recruiting

Prediction Model for MINS After Major Hepatobiliary Surgery

Postoperative ComplicationsLiver NeoplasmMyocardial Injury After Noncardiac Surgery (MINS)+1 more
Beijing Tsinghua Chang Gung Hospital1,800 enrolled6 locationsNCT07335042
Recruiting

Incidence and Outcome of Perioperative Myocardial Injury After Non-cardiac Surgery

Perioperative Myocardial Injury
University Hospital, Basel, Switzerland19,645 enrolled1 locationNCT02573532
Recruiting
Not Applicable

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Myocardial InjuryHip Fractures
Population Health Research Institute1,100 enrolled70 locationsNCT04743765
Recruiting

Anesthesia Induced Myocardial Injury in Non-cardiac Surgery (AIMY)

Perioperative Myocardial Injury
University Hospital Tuebingen3,000 enrolled1 locationNCT07179029
Recruiting
Phase 4

GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery

Myocardial Injury
The University of Hong Kong372 enrolled3 locationsNCT06324461
Recruiting

ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Transplant Biopsies - A Pilot Study

Myocardial InjuryOrgan PreservationHeart Transplantation+3 more
Medical University of Vienna50 enrolled1 locationNCT06982404
Recruiting
Not Applicable

CRP Apheresis in STEMI

Myocardial InjuryC-Reactive ProteinST Elevation Myocardial Infarction+1 more
Medical University Innsbruck202 enrolled5 locationsNCT04939805
Recruiting

Mechanisms And Prognosis of Stroke-Heart Syndrome

Heart FailureStrokeMyocardial Injury+5 more
Chensheng Pan658 enrolled1 locationNCT06954103
Recruiting
Phase 3

Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery

Cardiovascular DiseasesCardiovascular ComplicationMyocardial Injury+2 more
Cantonal Hospital of St. Gallen880 enrolled1 locationNCT06279000
Recruiting

Implementation of a Clinical Screening and Response System for Cardiac Complications After Noncardiac Surgery

Myocardial InjuryMyocardial InfarctionPerioperative Complication
University Hospital, Basel, Switzerland900 enrolled5 locationsNCT05859620
Recruiting
Phase 2

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

Myocardial InjuryAcute Kidney InjuryIschemia Reperfusion Injury
Kaiser Permanente304 enrolled1 locationNCT04750616
Recruiting

Monitoring of Vital Signs for Phenotyping of Perioperative Myocardial Infarction/Injury After Noncardiac Surgery

Perioperative Myocardial InjuryPerioperative Myocardial Infarction
University Hospital, Basel, Switzerland875 enrolled1 locationNCT05866874
Recruiting

Endothelial Dysfunction and Non-cardiac Surgery

SurgeryStrokeMyocardial Injury+1 more
University of Chile200 enrolled1 locationNCT05778981
Recruiting
Phase 2

Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.

Heart FailureMyocardial InjuryCoronary Artery Disease+1 more
Ralf Rothoerl36 enrolled1 locationNCT06705023
Recruiting
Phase 3

Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia.

PneumoniaMyocardial Injury
Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica178 enrolled7 locationsNCT06296212
Recruiting

CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)

Myocardial InjuryComplicationsTherapy+4 more
Wonju Severance Christian Hospital1,500 enrolled1 locationNCT04490317
Recruiting

Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL)

Myocardial InjuryTakotsubo CardiomyopathyMyocarditis; Acute or Subacute+1 more
Salamanca University Hospital300 enrolled1 locationNCT06506071
Recruiting

Cellular precOnditioning for Post-Surgical Myocardial Ischemic Complications - Observational Study

Myocardial InjuryMyocardial IschemiaMyocardial Infarction+1 more
Ottawa Hospital Research Institute12 enrolled1 locationNCT05762601